Maze Therapeutics
Trade Maze Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MAZE
Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM diseases. Its pipeline includes the Compass platform, which allows it to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process to refer a variant functionalization.
MAZE Key Statistics
Stock Snapshot
Maze Therapeutics(MAZE) stock is priced at $26.26, giving the company a market capitalization of 1.45B. It carries a P/E multiple of -9.47.
As of 2026-05-05, Maze Therapeutics(MAZE) stock has fluctuated between $26.16 and $27.58. The current price stands at $26.26, placing the stock +0.4% above today's low and -4.8% off the high.
Maze Therapeutics(MAZE) shares are trading with a volume of 304.53K, against a daily average of 764.95K.
In the last year, Maze Therapeutics(MAZE) shares hit a 52-week high of $53.65 and a 52-week low of $8.25.
In the last year, Maze Therapeutics(MAZE) shares hit a 52-week high of $53.65 and a 52-week low of $8.25.
Analyst ratings
100%
of 12 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.